Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar.

Buurman DJ, Blokzijl T, Festen EAM, Pham BT, Faber KN, Brouwer E, Dijkstra G.

PLoS One. 2018 Dec 11;13(12):e0208922. doi: 10.1371/journal.pone.0208922. eCollection 2018.

2.

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Visschedijk MC, Spekhorst LM, Cheng SC, van Loo ES, Jansen BHD, Blokzijl T, Kil H, de Jong DJ, Pierik M, Maljaars JPWJ, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Nieuwenhuijs VB, Imhann F, van Sommeren S, Alberts R, Xavier RJ, Dijkstra G, Nico Faber K, Aldaz CM, Weersma RK, Festen EAM.

J Crohns Colitis. 2018 Apr 27;12(5):582-588. doi: 10.1093/ecco-jcc/jjy001.

PMID:
29361163
3.

The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut.

von Martels JZH, Sadaghian Sadabad M, Bourgonje AR, Blokzijl T, Dijkstra G, Faber KN, Harmsen HJM.

Anaerobe. 2017 Apr;44:3-12. doi: 10.1016/j.anaerobe.2017.01.001. Epub 2017 Jan 3. Review.

PMID:
28062270
4.

HSPA6 is an ulcerative colitis susceptibility factor that is induced by cigarette smoke and protects intestinal epithelial cells by stabilizing anti-apoptotic Bcl-XL.

Regeling A, Imhann F, Volders HH, Blokzijl T, Bloks VW, Weersma RK, Dijkstra G, Faber KN.

Biochim Biophys Acta. 2016 Apr;1862(4):788-796. doi: 10.1016/j.bbadis.2016.01.020. Epub 2016 Jan 26.

5.

A simple coculture system shows mutualism between anaerobic faecalibacteria and epithelial Caco-2 cells.

Sadaghian Sadabad M, von Martels JZ, Khan MT, Blokzijl T, Paglia G, Dijkstra G, Harmsen HJ, Faber KN.

Sci Rep. 2015 Dec 15;5:17906. doi: 10.1038/srep17906.

6.

The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients.

Sadaghian Sadabad M, Regeling A, de Goffau MC, Blokzijl T, Weersma RK, Penders J, Faber KN, Harmsen HJ, Dijkstra G.

Gut. 2015 Oct;64(10):1546-52. doi: 10.1136/gutjnl-2014-307289. Epub 2014 Sep 24.

PMID:
25253126
7.

Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.

Parikh K, Zhou L, Somasundaram R, Fuhler GM, Deuring JJ, Blokzijl T, Regeling A, Kuipers EJ, Weersma RK, Nuij VJ, Alves M, Vogelaar L, Visser L, de Haar C, Krishnadath KK, van der Woude CJ, Dijkstra G, Faber KN, Peppelenbosch MP.

Sci Transl Med. 2014 Apr 23;6(233):233ra53. doi: 10.1126/scitranslmed.3006763.

8.

Histopathologic and molecular evaluation of the Organ Procurement and Transplantation Network selection criteria for intestinal graft donation.

Roskott AM, van Haaften WT, Leuvenink HG, Ploeg RJ, van Goor H, Blokzijl T, Ottens PJ, Dijkstra G, Nieuwenhuijs VB.

J Surg Res. 2014 Jun 1;189(1):143-51. doi: 10.1016/j.jss.2014.02.008. Epub 2014 Feb 18.

PMID:
24655665
9.

Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme.

van der Logt EM, Blokzijl T, van der Meer R, Faber KN, Dijkstra G.

J Nutr Biochem. 2013 Jun;24(6):1159-65. doi: 10.1016/j.jnutbio.2012.09.001. Epub 2012 Dec 12.

PMID:
23246033
10.

Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.

Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P, van den Berg A.

Mod Pathol. 2009 Apr;22(4):547-55. doi: 10.1038/modpathol.2009.10. Epub 2009 Mar 13.

11.

Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ, van den Berg A.

Neoplasia. 2009 Feb;11(2):167-76.

12.

The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile.

Ma Y, Visser L, Blokzijl T, Harms G, Atayar C, Poppema S, van den Berg A.

Lab Invest. 2008 May;88(5):482-90. doi: 10.1038/labinvest.2008.24. Epub 2008 Mar 24.

13.

miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.

Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A.

J Pathol. 2008 May;215(1):13-20. doi: 10.1002/path.2333.

PMID:
18348159
14.

Microarray amplification bias: loss of 30% differentially expressed genes due to long probe - poly(A)-tail distances.

Boelens MC, te Meerman GJ, Gibcus JH, Blokzijl T, Boezen HM, Timens W, Postma DS, Groen HJ, van den Berg A.

BMC Genomics. 2007 Aug 15;8:277.

15.

Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.

Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E, Jacobs S, Poppema S, Kroesen BJ.

Oncogene. 2007 May 31;26(26):3769-76. Epub 2006 Dec 18.

PMID:
17173072
16.

Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments.

Atayar C, van den Berg A, Blokzijl T, Boot M, Gascoyne RD, Visser L, Poppema S.

J Clin Pathol. 2007 Oct;60(10):1092-7. Epub 2006 Dec 8.

17.

Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma.

Kluiver J, Kok K, Pfeil I, de Jong D, Blokzijl T, Harms G, van der Vlies P, Diepstra A, Atayar C, Poppema S, Küppers R, van den Berg A.

Hematol Oncol. 2007 Mar;25(1):21-9.

PMID:
17048263
18.

BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV.

Atayar C, Kok K, Kluiver J, Bosga A, van den Berg E, van der Vlies P, Blokzijl T, Harms G, Davelaar I, Sikkema-Raddatz B, Martin-Subero JI, Siebert R, Poppema S, van den Berg A.

Hum Pathol. 2006 Jun;37(6):675-83.

PMID:
16733207
19.

Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis.

Rust R, Kluiver J, Visser L, Harms G, Blokzijl T, Kamps W, Poppema S, van den Berg A.

J Pathol. 2006 Aug;209(4):474-83.

PMID:
16718746
20.

High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma.

Rust R, Visser L, van der Leij J, Harms G, Blokzijl T, Deloulme JC, van der Vlies P, Kamps W, Kok K, Lim M, Poppema S, van den Berg A.

Br J Haematol. 2005 Dec;131(5):596-608.

PMID:
16351635
21.

Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.

Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A.

Genes Chromosomes Cancer. 2006 Feb;45(2):147-53.

PMID:
16235244
22.

BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.

Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A.

J Pathol. 2005 Oct;207(2):243-9.

PMID:
16041695
23.

TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells.

Rust R, Blokzijl T, Harms G, Lim M, Visser L, Kamps WA, Poppema S, van den Berg A.

J Pathol. 2005 Aug;206(4):445-50.

PMID:
15920698
24.

High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.

Rust R, Harms G, Blokzijl T, Boot M, Diepstra A, Kluiver J, Visser L, Peh SC, Lim M, Kamps WA, Poppema S, van den Berg A.

J Clin Pathol. 2005 May;58(5):520-4.

25.

Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.

Atayar C, Poppema S, Blokzijl T, Harms G, Boot M, van den Berg A.

Am J Pathol. 2005 Jan;166(1):127-34.

26.

Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response.

van der Leij J, van den Berg A, Blokzijl T, Harms G, van Goor H, Zwiers P, van Weeghel R, Poppema S, Visser L.

J Pathol. 2004 Dec;204(5):511-8.

PMID:
15538736
27.

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H, Packeisen J, Sewalt RA, Otte AP, van Diest PJ.

Neoplasia. 2003 Nov-Dec;5(6):481-8.

28.

Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.

Raaphorst FM, Vermeer M, Fieret E, Blokzijl T, Dukers D, Sewalt RG, Otte AP, Willemze R, Meijer CJ.

Am J Pathol. 2004 Feb;164(2):533-42.

29.

High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells.

van der Leij J, van den Berg A, Albrecht EW, Blokzijl T, Roozendaal R, Gouw AS, de Jong KP, Stegeman CA, van Goor H, Chang NS, Poppema S.

Transplantation. 2003 Jun 27;75(12):2076-82.

PMID:
12829915
30.

High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.

van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E, Poppema S.

Genes Chromosomes Cancer. 2003 May;37(1):20-8.

PMID:
12661002
31.

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ.

Blood. 2001 Jun 15;97(12):3896-901.

32.

Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation.

Raaphorst FM, Otte AP, van Kemenade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Meijer CJ.

J Immunol. 2001 May 15;166(10):5925-34.

33.

Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

Raaphorst FM, van Kemenade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ.

Am J Pathol. 2000 Sep;157(3):709-15.

Supplemental Content

Loading ...
Support Center